Search Tag: diabetes mellitus
2023 22 Jul
Cardiovascular disease remains a major worldwide public health problem and despite significant advances in diagnosis and treatment, coronary artery disease represents the leading cause of death in the developed world. In some specific patient populations, such as including subjects with asymptomatic CAD, diabetes mellitus, obesity, and kidney or...Read more
2023 22 Jul
Cardiovascular disease remains a major worldwide public health problem and despite significant advances in diagnosis and treatment, coronary artery disease represents the leading cause of death in the developed world. In some specific patient populations, such as including subjects with asymptomatic CAD, diabetes mellitus, obesity, and kidney or...Read more
2023 19 Apr
Diabetes mellitus (DM) is a chronic disease that is becoming increasingly common in the general population. An estimated 537 million people worldwide have DM. Its prevalence is expected to increase to 700 million by 2045. Approximately 1 in 11 adults in Europe have DM, roughly 61 million individuals. Patients with diabetes account for 15% of...Read more
2019 01 Sep
Investigators from Brigham and Women's Hospital and Greater Paris University Hospitals - AP-HP/Université de Paris presented the results from The Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study (THEMIS) study at the ESC Congress in Paris. The THEMIS trial evaluated whether adding ticagrelor to aspirin improved...Read more
2019 31 Aug
New findings from the CHAT-DM study presented at the ESC Congress today report that text message intervention can result in better glycaemic control in patients with diabetes mellitus and coronary heart disease. Findings were just published in Circulation: Cardiovascular Quality and Outcomes. According to the study author Dr. Xiqian Huo of...Read more
2017 05 Jun
Considering current trial results, patients with diabetes and heart failure may benefit most from glucose-lowering therapies with sodium glucose cotransporter 2 (SGLT2) inhibition, according to a review paper to appear in the American Journal of Cardiology. The beneficial effects of such therapies may be due to "the elimination of glucose via the...Read more
2014 20 Nov
In a recent study published in JAMA and presented at the American Heart Association’s Scientific Sessions 2014, Joseph B. Muhlestein, MD, and colleagues at the Intermountain Medical Center Heart Institute in Murray, Utah (USA) examined whether screening patients with diabetes deemed to be at high cardiac risk using coronary computed tomographic angiography...Read more